Eli Lilly and Company in the United States developed and produced selpercatinib. The specification of selpercatinib is 40mg/120 capsules, and the price is approximately $662. There are various manufacturers of selpercatinib, and prices vary depending on the manufacturer, selpercatinib, and sales channels, and are influenced by multiple factors.
Serpatinib is an important drug, and its application in the medical field has at···【more】
Release date:2024-12-24Recommended:102
Serpatinib is an important therapeutic drug, and its price, side effects and sid···【more】
Release date:2024-12-23Recommended:92
With the rapid development of medical technology, new drugs are emerging, among ···【more】
Release date:2024-12-23Recommended:86
Serpatinib is an important drug, and its price and precautions in the process of···【more】
Release date:2024-12-23Recommended:107
As a RET gene-targeted drug, Selpercatinib can effectively treat RET-related can···【more】
Release date:2024-08-15Recommended:127
Serpatinib is an innovative cancer treatment that targets mutations in the RET g···【more】
Release date:2024-08-15Recommended:134
Selpercatinib has a significant effect on RET-mutated cancers, especially in the···【more】
Release date:2024-08-15Recommended:114